Joon Young Choi
Overview
Explore the profile of Joon Young Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
350
Citations
3936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi J
Tuberc Respir Dis (Seoul)
. 2025 Mar;
PMID: 40051185
Chronic obstructive pulmonary disease (COPD) is a major global health issue, with acute exacerbations (AECOPD) significantly worsening outcomes and increasing healthcare burden. This review explores non-pharmacologic strategies aimed at preventing...
2.
Whi W, Lee H, Hong J, Kang W, Cho Y, Moon S, et al.
Anticancer Res
. 2025 Mar;
45(3):1273-1280.
PMID: 40037882
Background/aim: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and treatment outcomes for advanced disease remain suboptimal. Immunotherapy, particularly atezolizumab plus bevacizumab, has shown promise in improving...
3.
Whi W, Moon S, Oh D, Chung M, Jeong H, Ahn M, et al.
Clin Nucl Med
. 2025 Mar;
50(4):301-306.
PMID: 40029798
Purpose: This study aimed to evaluate the diagnostic performance of surveillance FDG PET/CT for detection of clinically unexpected recurrent disease or second primary malignancy in head and neck squamous cell...
4.
Choi J, Choi J, Woo S, Moon J, Lim C, Park S, et al.
J Pers Med
. 2025 Feb;
15(2).
PMID: 39997352
In the original publication [...].
5.
Choi J, Park Y, Lee H, Kwon H, Oh J, Lim C, et al.
Nucl Med Mol Imaging
. 2025 Jan;
59(1):27-40.
PMID: 39881970
Abstract: This guideline outlines the use of F-fluoro-2-deoxyglucose positron emission tomography / computed tomography for the diagnosis and management of infectious and inflammatory diseases. It provides detailed recommendations for healthcare...
6.
Park Y, Choi J, Lee H, Moon S, Lee I, Lee J, et al.
Nucl Med Mol Imaging
. 2025 Jan;
59(1):41-49.
PMID: 39881969
This guideline outlines the use of 3,4-dihydroxy-6-F-fluoro-L-phenylalanine positron emission tomography / computed tomography for the diagnosis and management of neuroendocrine tumors, brain tumors, and other tumorous conditions. It provides detailed...
7.
Nam J, Kim K, Rhee C, Choi J, Jo Y
J Thorac Dis
. 2025 Jan;
16(12):8379-8388.
PMID: 39831231
Background: The benefits of pulmonary rehabilitation (PR) for patients with idiopathic pulmonary fibrosis (IPF) have been limited to improving dyspnea, exercise capacity, and quality of life (QoL). This study aimed...
8.
Lee E, Lee S, Seong Y, Ku B, Cho H, Kim K, et al.
Transl Lung Cancer Res
. 2025 Jan;
13(12):3741-3763.
PMID: 39830742
Lung cancer is a malignant tumor with high incidence and mortality rates in both men and women worldwide. Although anticancer drugs are prescribed to treat lung cancer patients, individual responses...
9.
Choi J, Kim K, Rhee C
Sci Rep
. 2025 Jan;
15(1):2427.
PMID: 39827278
The COVID-19 pandemic has profoundly affected global health system, significantly altering not only the acute management of viral infection, but also management strategies for chronic diseases. This study aimed to...
10.
Whi W, Lee H, Cho Y, Lee H, Yoo H, Chung M, et al.
Sci Rep
. 2025 Jan;
15(1):143.
PMID: 39747497
The study investigates the prognostic value of [F]fluorodeoxyglucose (FDG) PET/CT in patients with idiopathic pulmonary fibrosis (IPF). A total of 346 IPF patients who underwent FDG PET/CT between 2007 and...